Entries by Lee Ann Crain

Houston Healthspan Innovation Group Launches to Transform Regenerative Medicine Research and Development

Houston-based accelerator to provide platform for growth to early stage life sciences and biotech companies HOUSTON, Sept. 24, 2019 /PRNewswire/ — Houston Healthspan Innovation Group is a new accelerator for early stage life sciences and biotech companies focused on the research, development and commercialization of new therapies and technologies in the expanding field of regenerative […]

Tissue Genesis’ Icellator® X Delivers Results in First Clinical Application

New leading-edge technology produces higher yields of stem cells to enhance patient treatments HOUSTON, Aug. 21, 2019 /PRNewswire/ — Tissue Genesis, a leading developer of cell therapy processing systems, announced today that an initial group of patients was successfully treated in the first clinical application of its Icellator® X technology at the Okyanos Center for […]

Rejenevie™ Therapeutics Announces Start of Phase Ib Immune Restoration Treatment Clinical Trial

Promising anti-aging stem cell therapy AR-100 shows potential in the treatment of age-related diseases HOUSTON, May 29, 2019 — Rejenevie™ Therapeutics announced the commencement of the company’s Phase Ib clinical trial to study the safety and effectiveness of its proprietary AR-100 immune restoration therapy to boost the function of the aging immune system. The clinical-stage […]

Dr. W.E. “Ed” Bosarge Jr. Introduces Waun Ki Hong Award Recipient at the American Association of Cancer Research’s Annual Meeting

ATLANTA (April 1, 2019) – W.E. “Ed” Bosarge Jr., PhD gave remarks Monday, April 1st, at the American Association of Cancer Research’s annual meeting in Atlanta. He introduced this year’s recipient of the AACR-Waun Ki Hong Award for Outstanding Achievement in Cancer Research, Dr. Andrew T. Chan.  Bosarge endows this $10,000 award given annually to an outstanding cancer researcher […]

TG & Human Life CORD, Japan Announce Exclusive Partnership

HOUSTON (Nov. 1, 2017) – Human Life CORD Japan, Inc., (HLC) a group company of Nihon Trim (Cord No. 6788, Tokyo Stock Exchange 1st Section) is pleased to announce a strategic agreement with Tissue Genesis, LLC (TG) to distribute its proprietary stem cell processing products in commercial clinics, research institutions, and hospitals in Japan and China. […]